Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Egger, Eva
MAMOC, NCT04227522: Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients	Completed	3	42	Europe	Rucaparib, Placebos	North Eastern German Society of Gynaecological Oncology, Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, Clovis Oncology, Inc.	Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Clear Cell Carcinoma	12/23	07/24
ECLAT, NCT03438474: Endometrial Cancer Lymphadenectomy Trial	Recruiting	N/A	640	Europe, Japan, RoW	Standard surgical procedure for endometrial cancer, systematic lymphadenectomy (LNE)	Philipps University Marburg, German Cancer Aid	Cancer of Endometrium Stage I, Cancer of Endometrium Stage II	02/28	02/29